Efficacy of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with ADHD: head-to-head responder analyses

被引:0
|
作者
Cardo, E. [1 ,2 ]
Coghill, D. [3 ]
Nagy, P. [4 ]
Adeyi, B. [5 ]
Anderson, C. [6 ]
Caballero, B. [7 ]
Higgins, N. [8 ]
Hodgkins, P. [9 ]
Civil, R. [10 ]
Dittmann, R. W. [11 ]
机构
[1] Univ Balearic Isl, Son Llatzer Hosp, Palma De Mallorca, Spain
[2] Res Inst Hlth Sci, Palma De Mallorca, Spain
[3] Univ Dundee, Div Neurosci, Dundee, Scotland
[4] Vadaskert Child & Adolescent Psychiat Hosp, Outpatient Clin, Budapest, Hungary
[5] Shire Dev LLC, Global Biostat, Wayne, NJ USA
[6] Shire Dev LLC, Global Clin Programs, Wayne, NJ USA
[7] Shire AG, Clin Dev & Med Affairs, Eysins, Switzerland
[8] Shire Dev LLC, Clin Programs, Wayne, NJ USA
[9] Shire Dev LLC, Global Hlth Econ & Outcomes Res, Wayne, NJ USA
[10] Shire Dev LLC, Clin Dev & Med Affairs, Wayne, NJ USA
[11] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany
关键词
D O I
10.1016/S0924-977X(13)70960-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.7.d.008
引用
收藏
页码:S603 / S604
页数:2
相关论文
共 50 条
  • [31] Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
    Mattos, Paulo
    REVISTA DE PSIQUIATRIA CLINICA, 2014, 41 (02): : 34 - 39
  • [32] Health-related quality of life outcomes in a long-term study of lisdexamfetamine dimesylate in children and adolescents with ADHD
    Coghill, D.
    Banaschewski, T.
    Zuddas, A.
    Johnson, M.
    Hodgkins, P.
    Adeyi, B.
    Squires, L.
    Civil, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S598 - S599
  • [33] Atomoxetine for children and adolescents with ADHD and reading disorders
    Sumner, Calvin
    Williams, David
    Hollandbeck, Millie
    Wietecha, Linda
    Tohen, Mauricio
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S82 - S82
  • [34] Review: methylphenidate and atomoxetine have similar efficacy and acceptability in children and adolescents with ADHD
    Ghuman, Jaswinder Kaur
    Breitborde, Nicholas J. K.
    EVIDENCE-BASED MENTAL HEALTH, 2012, 15 (03) : 74 - 74
  • [35] Reading Performance as a Function of Treatment With Lisdexamfetamine Dimesylate in Elementary School Children Diagnosed With ADHD
    Wigal, Sharon B.
    Maltas, Stephanie
    Crinella, Francis
    Stehli, Annamarie
    Steinhoff, Kenneth
    Lakes, Kimberley
    Schuck, Sabrina
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (01) : 23 - 33
  • [36] Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Childress, Ann C.
    Cutler, Andrew J.
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (04): : 395 - 405
  • [37] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    CNS DRUGS, 2017, 31 (07) : 625 - 638
  • [38] Growth and sexual maturation in a 2-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD
    Otero, I. Hernandez
    Banaschewski, T.
    Johnson, M.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Yan, B.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2017, 41 : S130 - S130
  • [39] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    David R. Coghill
    Tobias Banaschewski
    Peter Nagy
    Isabel Hernández Otero
    César Soutullo
    Brian Yan
    Beatriz Caballero
    Alessandro Zuddas
    CNS Drugs, 2017, 31 : 625 - 638
  • [40] Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Zuddas, A.
    Banaschewski, T.
    Nagy, P.
    Soutullo, C.
    Yan, B.
    Caballero, B.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S648 - S648